Q32 Bio Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Q32 Bio Inc.
Former names
Homology Medicines, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Waltham
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
QTTB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001661998
EIN
47-3468154

Board of directors

Follow this board

Chief executives

Since March 2024
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

581.8% a year in revenue

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Director election results

Annual meeting of June 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 21 other boards. 19 are in the same sector.

Network of Q32 Bio Inc.'s board connections Jade Biosciences Inc. Jade Biosciences Inc. Vor Biopharma Inc. Vor Biopharma Inc. Addex Therapeutics Ltd Addex Therapeutics Ltd Aktis Oncology Inc. Aktis Oncology Inc. Alaunos Therapeutics Inc. Alaunos Therapeutics I... Bolt Biotherapeutics Inc. Bolt Biotherapeutics I... CervoMed Inc. CervoMed Inc. Cullinan Therapeutics Inc. Cullinan Therapeutics... Entrada Therapeutics Inc. Entrada Therapeutics I... Immatics N.V. Immatics N.V. Inhibikase Therapeutics Inc. Inhibikase Therapeutic... KALA BIO Inc. KALA BIO Inc. Kardigan Inc. Kardigan Inc. OnKure Therapeutics Inc. OnKure Therapeutics In... Precipio Inc. Precipio Inc. Rainier Acquisition Corporation Rainier Acquisition Co... Alise Reicin Alise Reicin David S. Grayzel David S. Grayzel Isaac Manke Isaac Manke Jeffrey Poulton V Jeffrey Poulton V Kathleen Laporte Kathleen Laporte Mark T. Iwicki Mark T. Iwicki Mary Thistle Mary Thistle Matthew R. Patterson Matthew R. Patterson Steven Gillis Steven Gillis Sven Ante Lundberg Sven Ante Lundberg Q32 Bio Inc.
Shared director Other board Same sector +5 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$30,000,000
4 purchases by 2 insiders
Sold, last 12 months
$459,748
8 sales by 3 insiders
Date Insider Transaction Shares Price Value
Aug 25, 2026 Kalowski Lee Officer (CFO and President) Open-market sale −3,972 $16.56 $65,776
Aug 25, 2026 Jodie Pope Morrison Director, Officer (CEO) Open-market sale −9,845 $16.56 $163,033
Aug 25, 2026 Violette Shelia M. Officer (Chief Scientific Officer) Open-market sale −2,798 $16.56 $46,335
Jul 16, 2026 Kalowski Lee Officer (CFO and President) Grant or award +53,250 — —
Jul 16, 2026 Jodie Pope Morrison Director, Officer (CEO) Grant or award +132,000 — —
Jul 16, 2026 Violette Shelia M. Officer (Chief Scientific Officer) Grant or award +37,500 — —
Jun 30, 2026 Isaac Manke Director Option exercise +53,521 $2.80 $149,859
May 28, 2026 Diyong Xu Director, 10% owner Open-market purchase +1,250,000 $8.00 $10,000,000
May 28, 2026 OrbiMed Capital GP VII LLC Director, 10% owner Open-market purchase +1,250,000 $8.00 $10,000,000
May 28, 2026 Diyong Xu Director, 10% owner Open-market purchase +625,000 $8.00 $5,000,000
May 28, 2026 OrbiMed Capital GP VII LLC Director, 10% owner Open-market purchase +625,000 $8.00 $5,000,000
Feb 25, 2026 Kalowski Lee Officer (CFO and President) Open-market sale −3,995 $4.51 $18,017
Feb 25, 2026 Jodie Pope Morrison Director, Officer (CEO) Open-market sale −9,896 $4.51 $44,631
Feb 25, 2026 Violette Shelia M. Officer (Chief Scientific Officer) Open-market sale −2,815 $4.51 $12,696
Feb 24, 2026 Violette Shelia M. Officer (Chief Scientific Officer) Grant or award +37,500 — —

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States

Questions about Q32 Bio Inc.

Who is the CEO of Q32 Bio Inc.?

Jodie Pope Morrison has been Q32 Bio Inc.'s CEO since March 2024.

How many directors are on Q32 Bio Inc.'s board?

Q32 Bio Inc.'s board has 14 directors: Albert Seymour, Alise Reicin, Arthur Tzianabos, David S. Grayzel, Diyong Xu, Isaac Manke, Jeffrey Poulton V, Jodie Pope Morrison, Kathleen Laporte, Mark T. Iwicki and 4 others.

Are Q32 Bio Inc. insiders buying or selling shares?

Over the last 12 months, Q32 Bio Inc. insiders bought $30.0 million of shares in 4 purchases and sold $459,748 of shares in 8 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Q32 Bio Inc. connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="q32-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.